glp-1 in development The transformative breakthroughs research recognized by the 2024 Lasker~DeBakey award | Current Medicine Oral Small-Molecule GLP-1 Receptor Agonists:

The safety and efficacy of these products are not guaranteed

Barriers and facilitators for implementation of a combined lifestyle intervention in community-dwelling older adults: a scoping review

Proportion of adults living with diabetes b : 11% Sources: The World Obesity Federation, World Population Review, International Diabetes Federation, Government of Canada, World Health Organization

Some providers may prescribe off-label for specific metabolic conditions, but this remains controversial and is not covered by any standard insurance plan

The effect of tirzepatide during weight loss on metabolic adaption, fat oxidation, and food intake in people with obesity

Cytokine Growth Factor Rev